118 Participants Needed

Death Language for Code Status Discussions

(CODE-EMRS Trial)

KJ
Overseen ByKarthik J Kota, MD MPH
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: Rutgers, The State University of New Jersey
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

In order to systematically improve code status communication and documentation while clarifying how providers understand code status decisions, we propose the Choice of Diction's Effect Electronic Measures of Resuscitation Study Inpatient (CODE-EMRS.I) with 3 aims: Aim 1 - Determine rate of patient utilization of code status invitation (research) via the Portal (Hypothesis 1: Participants with an existing Portal are more likely to participate in research than new signups); Aim 2 - Evaluate different phrasings in code status prompts with and without death language (Hypothesis 2: Participants are more likely to pick no code with death language than without); Aim 3 - Determine how objective data drives physician agreement on code status decision (Hypothesis 3: Physicians are more likely to disagree with full code decisions for poor GO-FAR, but not CCI). Participants will fill out all study questionnaires electronically, but have options within these to ask to speak to a study physician/their own physician for clarification. After completing the surveys, the research associate will deliver the patient's code status decision to the attending of record and ask their views on it. Once a week, participants who have expressed interest in the study (by clicking the "I am interested" button) but have not completed the study will receive a reminder to complete the study as well as an offer to withdraw from the study in that same communication.

Who Is on the Research Team?

KJ

Karthik J Kota, MD MPH

Principal Investigator

Assistant Professor of Medicine

Are You a Good Fit for This Trial?

This trial is for English-speaking individuals over the age of 65 who can consent to participate. It aims to improve how code status preferences are communicated and documented in medical records, focusing on patients' choices regarding resuscitation efforts.

Inclusion Criteria

I am older than 65.
I am fluent in reading and speaking English.
I am able to understand and agree to the study's requirements.

Exclusion Criteria

Requiring ICU-level care

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Survey Completion

Participants fill out study questionnaires electronically and have options to speak to a study physician for clarification

2-4 weeks
Remote participation

Follow-up

Participants receive weekly reminders to complete the study and have the option to withdraw

4 weeks
Weekly remote reminders

What Are the Treatments Tested in This Trial?

Interventions

  • Death Language

Trial Overview

The study tests different ways of asking patients about their resuscitation preferences using 'death language' in electronic medical records. It examines if certain phrasings influence decisions and how doctors agree with these choices based on objective data.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Experimental/Death languageExperimental Treatment1 Intervention
Group II: Standard/non-death languageActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials
471
Recruited
81,700+